Immobilization of purified enzyme EreB in metalorganic framework (MOF) mesopores for erythromycin degradation
Copyright © 2023 Elsevier Inc. All rights reserved..
Erythromycin, a commonly used macrolide antibiotic, plays a crucial role in both human medicine and animal husbandry. However, its abuse has led to residual presence in the environment, with problems such as the emergence of resistant bacteria and enrichment of resistance genes. These issues pose significant risks to human health. Thus far, there are no effective, environmentally friendly methods to manage this problem. Enzymes can specifically degrade erythromycin without causing other problems, but their unrecyclability and environmental vulnerability hinder large-scale application. Enzyme immobilization may help to solve these problems. This study used Cu-BTC, a synthetic metal-organic framework, to immobilize the erythromycin-degrading enzyme EreB. The loading temperature and enzyme quantity were optimized. The Cu-BTC and EreBCu-BTC were characterized by various methods to confirm the preparation of Cu-BTC and immobilization of EreB. The maximum enzyme loading capacity was 66.5 mg g-1. In terms of enzymatic properties, immobilized EreB had improved heat (25-45 °C) and alkaline (6.5-10) tolerance, along with greater affinity between the enzyme and its substrate; Km decreased from 438.49 to 372.30 mM. Recycling was also achieved; after 10 cycles, 57.12% of the enzyme activity was maintained. After composite degradation, the antibacterial activity of erythromycin-containing wastewater was examined; the results showed that the novel composite could completely inactivate erythromycin. In summary, Cu-BTC was an ideal carrier for immobilization of the enzyme EreB, and the EreB@Cu-BTC composite has good prospects for the treatment of erythromycin-containing wastewater.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:237 |
|---|---|
| Enthalten in: |
Environmental research - 237(2023), Pt 2 vom: 15. Nov., Seite 117023 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ni, Shensheng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibacterial activity |
|---|
| Anmerkungen: |
Date Revised 22.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.envres.2023.117023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36155365X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36155365X | ||
| 003 | DE-627 | ||
| 005 | 20231226085403.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.envres.2023.117023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1205.xml |
| 035 | |a (DE-627)NLM36155365X | ||
| 035 | |a (NLM)37657601 | ||
| 035 | |a (PII)S0013-9351(23)01827-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ni, Shensheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immobilization of purified enzyme EreB in metalorganic framework (MOF) mesopores for erythromycin degradation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Erythromycin, a commonly used macrolide antibiotic, plays a crucial role in both human medicine and animal husbandry. However, its abuse has led to residual presence in the environment, with problems such as the emergence of resistant bacteria and enrichment of resistance genes. These issues pose significant risks to human health. Thus far, there are no effective, environmentally friendly methods to manage this problem. Enzymes can specifically degrade erythromycin without causing other problems, but their unrecyclability and environmental vulnerability hinder large-scale application. Enzyme immobilization may help to solve these problems. This study used Cu-BTC, a synthetic metal-organic framework, to immobilize the erythromycin-degrading enzyme EreB. The loading temperature and enzyme quantity were optimized. The Cu-BTC and EreBCu-BTC were characterized by various methods to confirm the preparation of Cu-BTC and immobilization of EreB. The maximum enzyme loading capacity was 66.5 mg g-1. In terms of enzymatic properties, immobilized EreB had improved heat (25-45 °C) and alkaline (6.5-10) tolerance, along with greater affinity between the enzyme and its substrate; Km decreased from 438.49 to 372.30 mM. Recycling was also achieved; after 10 cycles, 57.12% of the enzyme activity was maintained. After composite degradation, the antibacterial activity of erythromycin-containing wastewater was examined; the results showed that the novel composite could completely inactivate erythromycin. In summary, Cu-BTC was an ideal carrier for immobilization of the enzyme EreB, and the EreB@Cu-BTC composite has good prospects for the treatment of erythromycin-containing wastewater | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antibacterial activity | |
| 650 | 4 | |a Cu-BTC | |
| 650 | 4 | |a Enzyme immobilization | |
| 650 | 4 | |a EreB | |
| 650 | 4 | |a Erythromycin | |
| 700 | 1 | |a Li, Chunyu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Wenfan |e verfasserin |4 aut | |
| 700 | 1 | |a Niu, Dongze |e verfasserin |4 aut | |
| 700 | 1 | |a Zhi, Junqiang |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Chongqing |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Xingmei |e verfasserin |4 aut | |
| 700 | 1 | |a Ren, Jianjun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Environmental research |d 1967 |g 237(2023), Pt 2 vom: 15. Nov., Seite 117023 |w (DE-627)NLM000029521 |x 1096-0953 |7 nnns |
| 773 | 1 | 8 | |g volume:237 |g year:2023 |g number:Pt 2 |g day:15 |g month:11 |g pages:117023 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.envres.2023.117023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 237 |j 2023 |e Pt 2 |b 15 |c 11 |h 117023 | ||